Page 8 - Logix Smart News Today

Strong results highlighted by record first quarter revenue of $22.7 million and diluted EPS of $0.34SALT LAKE CITY, May 12, 2022 /PRNewswire/ --  ...

Co-Diagnostics (NASDAQ:CODX) Inc saw a healthy jump in year-over-year revenue driven by global sales of its Logix Smart COVID-19 tests, according to its...

Co-Diagnostics, Inc. (NASDAQ:NASDAQ:CODX) Q4 2021 Results Conference Call March 24, 2022 04:30 PM ET Company Participants Andrew Benson - Head, IR Dwight Egan - CEO Brian Brown - CFO...

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Co-Diagnostics (NASDAQ:CODX) Inc saw a healthy jump in year-over-year revenue driven by global sales of its Logix Smart COVID-19 tests, according to its...

The molecular testing company is expected to benefit from the rise in cases of the omicron COVID-19 variant.

Co-Diagnostics said it has been developing its upcoming sample-to-answer YourTest at-home/point-of-care diagnostic device with the two privately held companies.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

SALT LAKE CITY, Nov. 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,

“We are pleased to report that none of the over 50 mutations in this new variant are close enough to the targets of any of our COVID-19...